Menu
Back to Journals » Drug Design, Development and Therapy » Volume 6
Review
Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, Fingolimod will change therapeutic paradigm approach
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 17,950 | Dovepress* | 13,986+ | 2,903 | 16,889 | |
| PubMed Central* | 3,964 | 1,620 | 5,584 | ||
| Totals | 17,950 | 4,523 | 22,473 | ||
|
*Since 19 July 2012 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 11 | 0 | 0 | 0 | 2 | 9 |
View citations on PubMed Central and Google Scholar